{"id":"W1996434966","doi":"10.1056/nejmoa040842","title":"Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection in HIV-Infected Patients","year":2004,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Hepatitis C virus research","field":"Medicine","cited_by":1235,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Ribavirin; Medicine; Internal medicine; Peginterferon alfa-2a; Gastroenterology; Hepatitis C; Placebo; Interferon alfa; Hepatitis C virus; Alpha interferon; Interferon; Virology; Immunology; Virus; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007362201,0.0002656149,0.0006271678,0.0002337792,0.0005376598,0.0002831179,0.0001692374,0.000394294,0.002176395],"category_scores_gemma":[0.001216717,0.0001385284,0.0003825139,0.0003230713,0.0001936045,0.0002121704,0.0002241796,0.0004437346,0.0002220623],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002893498,"about_ca_system_score_gemma":0.0007227069,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004622833,"about_ca_topic_score_gemma":0.0008835471,"domain_scores_codex":[0.9996809,0.0001591154,0.00003478289,0.00003513066,0.00004098485,0.00004905081],"domain_scores_gemma":[0.9994543,0.0001858907,0.00009968639,0.00001458655,0.00002422058,0.0002212371],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.2046399,0.007781123,0.4666355,0.001254756,0.001072399,0.001531453,0.0003596152,0.001946215,0.01376517,0.0002896224,0.003855581,0.2968687],"study_design_scores_gemma":[0.07240884,0.1543419,0.7473528,0.0005172978,0.001238295,0.004814291,0.0004037881,0.003329201,0.00335625,0.0006204931,0.01155755,0.00005926243],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9957119,0.002762231,0.0001265219,0.0002281804,0.00004115639,0.0002297394,0.0001275771,0.000007061997,0.0007655563],"genre_scores_gemma":[0.9970936,0.001317734,0.0004577902,0.0003220358,0.0001164399,0.0002408764,0.0001817016,0.000001472806,0.0002683662],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002176395,"threshold_uncertainty_score":0.007280767,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02563220288722058,"score_gpt":0.3223026156713883,"score_spread":0.2966704127841677,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}